SK128594A3 - 1,2-dihydro-2-oxopyridines - Google Patents
1,2-dihydro-2-oxopyridines Download PDFInfo
- Publication number
- SK128594A3 SK128594A3 SK1285-94A SK128594A SK128594A3 SK 128594 A3 SK128594 A3 SK 128594A3 SK 128594 A SK128594 A SK 128594A SK 128594 A3 SK128594 A3 SK 128594A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- dihydro
- group
- compound
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4336051A DE4336051A1 (de) | 1993-10-22 | 1993-10-22 | 1,2-Dihydro-2-oxo-pyridine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK128594A3 true SK128594A3 (en) | 1995-05-10 |
Family
ID=6500753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1285-94A SK128594A3 (en) | 1993-10-22 | 1994-10-21 | 1,2-dihydro-2-oxopyridines |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0657435A3 (cs) |
| JP (1) | JPH07242664A (cs) |
| KR (1) | KR950011409A (cs) |
| CN (1) | CN1106388A (cs) |
| AU (1) | AU7593294A (cs) |
| CA (1) | CA2133939A1 (cs) |
| CZ (1) | CZ258594A3 (cs) |
| DE (1) | DE4336051A1 (cs) |
| HU (1) | HU9403060D0 (cs) |
| NO (1) | NO944024L (cs) |
| PL (1) | PL305514A1 (cs) |
| RU (1) | RU94037954A (cs) |
| SK (1) | SK128594A3 (cs) |
| ZA (1) | ZA948311B (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0100873D0 (sv) * | 2001-03-13 | 2001-03-13 | Astrazeneca Ab | Method of treatment |
| JP6281735B2 (ja) * | 2013-03-19 | 2018-02-21 | トーアエイヨー株式会社 | 急性心不全治療薬の評価方法、及び、急性心不全モデルの作製方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2037630C (en) * | 1990-03-07 | 2001-07-03 | Akira Morimoto | Nitrogen-containing heterocylic compounds, their production and use |
| CA2051705A1 (en) * | 1990-06-19 | 1991-12-20 | Kiyoaki Katano | Pyridine derivatives having angiotensin ii antagonism |
| IL100917A0 (en) * | 1991-02-16 | 1992-11-15 | Fisons Plc | Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them |
| DE4129340A1 (de) * | 1991-09-04 | 1993-03-11 | Merck Patent Gmbh | 1,2-dihydro-2-oxopyridine |
| DE4334308A1 (de) * | 1993-10-08 | 1995-04-13 | Merck Patent Gmbh | 1,2-Dihydro-2-oxo-3-methylsulfonylaminomethyl-pyridine |
-
1993
- 1993-10-22 DE DE4336051A patent/DE4336051A1/de not_active Withdrawn
-
1994
- 1994-10-10 EP EP94115937A patent/EP0657435A3/de not_active Withdrawn
- 1994-10-19 AU AU75932/94A patent/AU7593294A/en not_active Abandoned
- 1994-10-20 JP JP6255555A patent/JPH07242664A/ja active Pending
- 1994-10-20 CA CA002133939A patent/CA2133939A1/en not_active Abandoned
- 1994-10-20 CN CN94117572A patent/CN1106388A/zh active Pending
- 1994-10-20 PL PL94305514A patent/PL305514A1/xx unknown
- 1994-10-20 CZ CZ942585A patent/CZ258594A3/cs unknown
- 1994-10-21 HU HU9403060A patent/HU9403060D0/hu unknown
- 1994-10-21 NO NO944024A patent/NO944024L/no unknown
- 1994-10-21 SK SK1285-94A patent/SK128594A3/sk unknown
- 1994-10-21 KR KR1019940026911A patent/KR950011409A/ko not_active Application Discontinuation
- 1994-10-21 ZA ZA948311A patent/ZA948311B/xx unknown
- 1994-10-21 RU RU94037954/04A patent/RU94037954A/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1106388A (zh) | 1995-08-09 |
| EP0657435A2 (de) | 1995-06-14 |
| CA2133939A1 (en) | 1995-04-23 |
| NO944024D0 (no) | 1994-10-21 |
| EP0657435A3 (de) | 1996-03-06 |
| AU7593294A (en) | 1995-05-11 |
| CZ258594A3 (en) | 1995-07-12 |
| JPH07242664A (ja) | 1995-09-19 |
| DE4336051A1 (de) | 1995-04-27 |
| KR950011409A (ko) | 1995-05-15 |
| PL305514A1 (en) | 1995-05-02 |
| RU94037954A (ru) | 1996-10-27 |
| NO944024L (no) | 1995-04-24 |
| HU9403060D0 (en) | 1994-12-28 |
| ZA948311B (en) | 1995-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU669895B2 (en) | Imidazopyridines | |
| RU2271358C2 (ru) | Производные бета-карболина, обладающие действием ингибиторов фосфодиэстеразы, фармацевтическая композиция (варианты), способ ее получения, способ ингибирования действия фосфодиэстеразы (варианты) и способ увеличения концентрации цгмф | |
| KR100373972B1 (ko) | 이미다조피리딘유도체 | |
| US5532276A (en) | Imidazopyridines | |
| AU2003212305B2 (en) | Cyclic amides | |
| CZ287394A3 (en) | Imadazopyridazines, process of their preparation and pharmaceutical compositions based thereon and process for preparing thereof | |
| US20020133023A1 (en) | Heteroarylalkanoic acids as integrin receptor antagonists | |
| JP2003512375A (ja) | Ｈｉｖ逆転写酵素阻害剤としての縮合ナフチリジン | |
| CZ291851B6 (cs) | Derivát arylalkanoylpyridazinu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje | |
| CZ372592A3 (en) | Imidazopyridine derivatives, process of their preparation and pharmaceutical preparation based thereon | |
| AU689468B2 (en) | Imidazopyridine | |
| KR20010086085A (ko) | 이미다조[４,５-ｃ]-피리딘-４-온-유도체 | |
| JP2022529466A (ja) | 二環式及び三環式化合物 | |
| HUT64342A (en) | Methods for producing imidazo-pyridines and pharmaceutical preparatives containing them as active agent | |
| SK128594A3 (en) | 1,2-dihydro-2-oxopyridines | |
| SK99298A3 (en) | 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine used as medicine acting on the central nervous system | |
| CZ220793A3 (en) | Imidazopyridines, process of their preparation and pharmaceutical preparations in which they are comprised | |
| JP2001525398A (ja) | 選択的β３アドレナリン作動性アゴニスト | |
| MXPA00000755A (en) | Benzothia(oxa)diazol derivatives and their use as endothelin-receptor antagonists | |
| JP2002532500A (ja) | １，４−ベンゾジアゼピノン誘導体並びにそれらのインテグリン拮抗薬としての使用 | |
| SK88493A3 (en) | Diazinediones, especially triazinediones, process of their production and their pharmaceutical compositions |